Dr Anna Schultze

Research Fellow
Pharmacoepidemiology - GSK Collaboration

Keppel Street
United Kingdom

Anna is a pharmacoepidemiologist who joined the Electronic Health Records Group at LSHTM in 2020. Before joining LSHTM, Anna worked as a senior research associate at the consultancy firm Evidera, where she designed and managed post-authorisation safety and comparative effectiveness studies, primarily using nationwide Scandinavian health registries. She completed a PhD in epidemiology at UCL in 2017, focusing on HIV drug resistance, and also holds an MSc in Epidemiology from LSHTM and a BSc in Human Sciences from UCL. 


Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health


Anna is interested in how we can use routinely collected data to study the effectiveness and safety of commonly used medications. Her current research focuses on the use of self-controlled designs for the analyses of clinical trial extension studies; she is also involved in a number of pharmacoepidemiological studies in COVID-19. 

Research Area
Primary care
Electronic health records
Randomised controlled trials

Selected Publications

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply.
Rentsch CT; DeVito NJ; MacKenna B; Morton CE; Bhaskaran K; Brown JP; Schultze A; Hulme WJ; Croker R; Walker AJ
The Lancet Rheumatology
Identifying Care Home Residents in Electronic Health Records - An OpenSAFELY Short Data Report
Schultze A; Bates C; Cockburn J; MacKenna B; Nightingale E; Curtis H; Hulme W; Morton C; Croker R; Bacon S
COVID-19 and inhaled corticosteroids-another piece in an expanding puzzle.
Schultze A; Douglas I
The Lancet. Respiratory medicine
Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform
Tazare J; Walker AJ; Tomlinson L; Hickman G; Rentsch CT; Williamson EJ; Bhaskaran K; Evans D; Wing K; Mathur R
Changes in the rate of cardiometabolic and pulmonary events during the COVID-19 pandemic
Walker AJ; Tazare J; Hickman G; Rentsch CT; Williamson EJ; Bhaskaran K; Evans D; Wing K; Mathur R; Wong AYS
OpenSAFELY: Risks of COVID-19 hospital admission and death for people with learning disabilities - a cohort study
Williamson EJ; McDonald HI; Bhaskaran K; Walker AJ; Bacon S; Davy S; Schultze A; Tomlinson L; Bates C; Ramsay M
Predicting COVID-19 related death using the OpenSAFELY platform
Williamson EJ; Tazare J; Bhaskaran K; McDonald HI; Walker AJ; Tomlinson L; Wing K; Bacon S; Bates C; Curtis HJ
See more Publications